Perioperative Troponin Screening Identifies Patients at Higher Risk for Major Cardiovascular Events in Noncardiac Surgery.

[1]  G. Guyatt,et al.  Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial , 2018, The Lancet.

[2]  Daniel Bolliger,et al.  Prediction of major cardiac events after vascular surgery , 2017, Journal of vascular surgery.

[3]  Pavel S. Roshanov,et al.  Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery , 2017, JAMA.

[4]  M. Minicucci,et al.  Goldman score, but not Detsky or Lee indices, predicts mortality 6 months after hip fracture , 2017, BMC Musculoskeletal Disorders.

[5]  S. Kristensen.  2014 ESC/ESA guidelines on noncardiac surgery: Cardiovascular assessment and management , 2017, Journal of Nuclear Cardiology.

[6]  P. Devereaux,et al.  Troponin elevations after non-cardiac, non-vascular surgery are predictive of major adverse cardiac events and mortality: a systematic review and meta-analysis. , 2016, British journal of anaesthesia.

[7]  C. Polanczyk,et al.  The impact of preoperative evaluation on perioperative events in patients undergoing cataract surgery: a cohort study , 2016, Eye.

[8]  B. Caramelli,et al.  The Ankle-Brachial Index is Associated With Cardiovascular Complications After Noncardiac Surgery , 2016, Angiology.

[9]  Phil Hider,et al.  Estimated need for surgery worldwide based on prevalence of diseases: a modelling strategy for the WHO Global Health Estimate. , 2015, The Lancet. Global health.

[10]  Biykem Bozkurt,et al.  2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[11]  P. Coriat,et al.  The Long-Term Impact of Early Cardiovascular Therapy Intensification for Postoperative Troponin Elevation After Major Vascular Surgery , 2014, Anesthesia and analgesia.

[12]  J. R. Braz,et al.  Intraoperative and Anesthesia-Related Cardiac Arrest and Its Mortality in Older Patients: A 15-Year Survey in a Tertiary Teaching Hospital , 2014, PloS one.

[13]  B. Gorenek,et al.  2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). , 2014, European heart journal.

[14]  S. Yusuf,et al.  Myocardial Injury after Noncardiac Surgery: A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes , 2014, Anesthesiology.

[15]  C. Polanczyk,et al.  Clinical Use of Ultrasensitive Cardiac Troponin I Assay in Intermediate- and High-Risk Surgery Patients , 2013, Disease markers.

[16]  Jeroen J. Bax,et al.  Third universal definition of myocardial infarction , 2013, Nature Reviews Cardiology.

[17]  C. Polanczyk,et al.  Prognostic value of perioperative N-terminal pro-B-type natriuretic peptide in noncardiac surgery. , 2013, Arquivos brasileiros de cardiologia.

[18]  V. L. Azevedo,et al.  Relevância de exames de rotina em pacientes de baixo risco submetidos a cirurgias de pequeno e médio porte , 2013 .

[19]  V. Azevedo,et al.  Relevance of routine testing in low-risk patients undergoing minor and medium surgical procedures. , 2013, Brazilian journal of anesthesiology.

[20]  G. Guyatt,et al.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012, JAMA.

[21]  Denis Xavier,et al.  Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery , 2011, Annals of Internal Medicine.

[22]  Edward J. Mills,et al.  Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. , 2008, Journal of the American College of Cardiology.

[23]  W. J. Filho,et al.  Prognostic Factors for Mortality Among Patients Above the 6th Decade Undergoing Non-Cardiac Surgery: (Cares – Clinical Assessment and Research in Elderly Surgical Patients) , 2008, Clinics.

[24]  Charles Weissman,et al.  Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. , 2003, Journal of the American College of Cardiology.

[25]  Peter J. Pronovost,et al.  Cardiac Troponin I Predicts Short-Term Mortality in Vascular Surgery Patients , 2002, Circulation.

[26]  R. Peto,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[27]  D. Sessler,et al.  Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. , 2017, The Canadian journal of cardiology.

[28]  L. Rohde,et al.  3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology , 2017, Arquivos brasileiros de cardiologia.